These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 11916106

  • 21. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females.
    Walsh KM, Leen E, Lean ME.
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1009-15. PubMed ID: 10557020
    [Abstract] [Full Text] [Related]

  • 22. Sibutramine: its mode of action and efficacy.
    Finer N.
    Int J Obes Relat Metab Disord; 2002 Dec; 26 Suppl 4():S29-33. PubMed ID: 12457297
    [Abstract] [Full Text] [Related]

  • 23. The effects of sibutramine on the microstructure of eating behaviour and energy expenditure in obese women.
    Halford JC, Boyland EJ, Cooper SJ, Dovey TM, Huda MS, Dourish CT, Dawson GR, Wilding JP.
    J Psychopharmacol; 2010 Jan; 24(1):99-109. PubMed ID: 18755818
    [Abstract] [Full Text] [Related]

  • 24. 5-HT(1A) activation counteracts cardiovascular but not hypophagic effects of sibutramine in rats.
    Thomas GH, Babbs AJ, Chatfield RE, Krülle TM, Widdowson PS, Provost D, McCormack JG.
    Obesity (Silver Spring); 2009 Mar; 17(3):467-73. PubMed ID: 19219064
    [Abstract] [Full Text] [Related]

  • 25. Sibutramine decreases body weight gain and increases energy expenditure in obese Zucker rats without changes in NPY and orexins.
    Casado A, Rodríguez VM, Portillo MP, Macarulla MT, Abecia LC, Echevarría E, Casis L.
    Nutr Neurosci; 2003 Apr; 6(2):103-11. PubMed ID: 12722985
    [Abstract] [Full Text] [Related]

  • 26. Sibutramine-induced anorexia: potent, dose-dependent and behaviourally-selective profile in male rats.
    Tallett AJ, Blundell JE, Rodgers RJ.
    Behav Brain Res; 2009 Mar 17; 198(2):359-65. PubMed ID: 19061919
    [Abstract] [Full Text] [Related]

  • 27. Effects of preexposure to dexfenfluramine, phentermine, dexfenfluramine-phentermine, or fluoxetine on sibutramine-induced hypophagia in the adult rat.
    Wellman PJ, Jones SL, Miller DK.
    Pharmacol Biochem Behav; 2003 Apr 17; 75(1):103-14. PubMed ID: 12759118
    [Abstract] [Full Text] [Related]

  • 28. Modalities of the food intake-reducing effect of sibutramine in humans.
    Chapelot D, Marmonier C, Thomas F, Hanotin C.
    Physiol Behav; 2000 Jan 17; 68(3):299-308. PubMed ID: 10716539
    [Abstract] [Full Text] [Related]

  • 29. Effects of sibutramine on resting metabolic rate and weight loss in overweight women.
    Seagle HM, Bessesen DH, Hill JO.
    Obes Res; 1998 Mar 17; 6(2):115-21. PubMed ID: 9545017
    [Abstract] [Full Text] [Related]

  • 30. Sibutramine produces dose-related weight loss.
    Bray GA, Blackburn GL, Ferguson JM, Greenway FL, Jain AK, Mendel CM, Mendels J, Ryan DH, Schwartz SL, Scheinbaum ML, Seaton TB.
    Obes Res; 1999 Mar 17; 7(2):189-98. PubMed ID: 10102256
    [Abstract] [Full Text] [Related]

  • 31. Sibutramine in overweight/obese hypertensive patients.
    Sharma AM.
    Int J Obes Relat Metab Disord; 2001 Dec 17; 25 Suppl 4():S20-3. PubMed ID: 11916102
    [Abstract] [Full Text] [Related]

  • 32. Sibutramine therapy in obese women--effects on plasma neuropeptide Y (NPY), insulin, leptin and beta-endorphin concentrations.
    Baranowska B, Wolińska-Witort E, Martyńska L, Chmielowska M, Mazurczak-Pluta T, Boguradzka A, Baranowska-Bik A.
    Neuro Endocrinol Lett; 2005 Dec 17; 26(6):675-9. PubMed ID: 16380708
    [Abstract] [Full Text] [Related]

  • 33. Sibutramine lost and found.
    Bosello O, Carruba MO, Ferrannini E, Rotella CM.
    Eat Weight Disord; 2002 Sep 17; 7(3):161-7. PubMed ID: 12452247
    [Abstract] [Full Text] [Related]

  • 34. The effect of sibutramine on energy expenditure and appetite during chronic treatment without dietary restriction.
    Hansen DL, Toubro S, Stock MJ, Macdonald IA, Astrup A.
    Int J Obes Relat Metab Disord; 1999 Oct 17; 23(10):1016-24. PubMed ID: 10557021
    [Abstract] [Full Text] [Related]

  • 35. [Pharma-clinics. Medication of the month. Sibutramine (Reductil)].
    Scheen AJ.
    Rev Med Liege; 2001 Sep 17; 56(9):656-9. PubMed ID: 11702509
    [Abstract] [Full Text] [Related]

  • 36. Influence of sibutramine on energy expenditure in African American women.
    Starling RD, Liu X, Sullivan DH.
    Obes Res; 2001 Apr 17; 9(4):251-6. PubMed ID: 11331428
    [Abstract] [Full Text] [Related]

  • 37. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat.
    Jackson HC, Bearham MC, Hutchins LJ, Mazurkiewicz SE, Needham AM, Heal DJ.
    Br J Pharmacol; 1997 Aug 17; 121(8):1613-8. PubMed ID: 9283694
    [Abstract] [Full Text] [Related]

  • 38. Measuring the effect of sibutramine for weight loss.
    Ransom T, Ur E.
    JAMA; 1997 Aug 17; 287(4):449-50. PubMed ID: 11798360
    [No Abstract] [Full Text] [Related]

  • 39. A review of the metabolic effects of sibutramine.
    Filippatos TD, Kiortsis DN, Liberopoulos EN, Mikhailidis DP, Elisaf MS.
    Curr Med Res Opin; 2005 Mar 17; 21(3):457-68. PubMed ID: 15811215
    [Abstract] [Full Text] [Related]

  • 40. Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity.
    Luque CA, Rey JA.
    Ann Pharmacother; 1999 Sep 17; 33(9):968-78. PubMed ID: 10492502
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.